• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Characterization of recombinant human factor VIII.

作者信息

Eaton D L, Hass P E, Riddle L, Mather J, Wiebe M, Gregory T, Vehar G A

出版信息

J Biol Chem. 1987 Mar 5;262(7):3285-90.

PMID:3102485
Abstract

Recently, complete human factor VIII DNA clones have been obtained and subsequently expressed in baby hamster kidney cells (Wood, W. I., Capon, D. J., Simonsen, C. C., Eaton, D. L., Gitschier, J., Keyt, B., Seeburg, P. H., Smith, D. H., Hollingshead, P., Wion, K. L., Delwart, E., Tuddenham, E. G. D., Vehar, G. A., and Lawn, R. M. (1984) Nature 312, 330-337). The recombinant factor VIII (rVIII) protein secreted from these cells has now been purified allowing its structural analysis and comparison to plasma-derived factor VIII (pdVIII). Analysis of purified rVIII by sodium dodecyl sulfate-polyacrylamide gel electrophoresis shows that it consists of multiple polypeptides with relative mobilities (Mr) ranging from 80,000-210,000. The same pattern of polypeptides is also observed for pdVIII resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The proteins associated with rVIII are recognized by pdVIII antibodies in a Western blot. When rVIII and pdVIII are subjected to isoelectric focusing they are resolved into a similar pattern of protein bands. Thrombin, factor Xa, and activated protein C, which modulate factor VIII activity by proteolysis, process rVIII in the same manner they do pdVIII. As is the case for pdVIII, thrombin activation of rVIII coagulant activity correlates with the generation of subunits with Mr of 73,000, 50,000 and 43,000. These subunits appear to form a metal-(perhaps Ca2+) linked complex. EDTA inactivates thrombin-activated rVIII and pdVIII, with the activity being regenerated after the addition of a molar excess of MnCl2. The results suggest that rVIII is structurally and functionally very similar to pdVIII.

摘要

相似文献

1
Characterization of recombinant human factor VIII.
J Biol Chem. 1987 Mar 5;262(7):3285-90.
2
Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.人凝血因子VIII的蛋白水解加工。凝血酶、因子Xa和活化蛋白C的特异性切割与凝血因子VIII凝血活性的激活和失活的相关性。
Biochemistry. 1986 Jan 28;25(2):505-12. doi: 10.1021/bi00350a035.
3
Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.rVIII-SingleChain 的理化特性,一种新型的重组单链因子 VIII。
Thromb Res. 2015 Aug;136(2):388-95. doi: 10.1016/j.thromres.2015.05.005. Epub 2015 May 16.
4
Phosphorylation of factor Va and factor VIIIa by activated platelets.活化血小板对因子Va和因子VIIIa的磷酸化作用。
Blood. 1993 Feb 1;81(3):704-19.
5
Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.新型重组单链八因子 rVIII-SingleChain(CSL627)的临床前疗效和安全性。
Thromb Res. 2013 Aug;132(2):280-7. doi: 10.1016/j.thromres.2013.06.017. Epub 2013 Jul 5.
6
A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.人重组衍生因子VIII的A2结构域是促凝血活性所必需的,但不是凝血酶切割所必需的。
Blood. 1992 Jan 15;79(2):389-97.
7
Human factor VIII: purification from commercial factor VIII concentrate, characterization, identification and radiolabeling.人凝血因子VIII:从商业性凝血因子VIII浓缩物中纯化、表征、鉴定及放射性标记
Biochim Biophys Acta. 1986 Oct 17;873(3):356-66. doi: 10.1016/0167-4838(86)90084-1.
8
Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A.从蛋白A的噬菌体展示组合文库中筛选出的重组人凝血因子VIII特异性亲和配体。
Eur J Biochem. 2001 Aug;268(15):4269-77. doi: 10.1046/j.1432-1327.2001.02344.x.
9
Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.新型重组因子VIII(缺乏大部分B结构域的因子VIII-δII)的结构与功能特性
Biochem J. 1991 Jul 1;277 ( Pt 1)(Pt 1):23-31. doi: 10.1042/bj2770023.
10
Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide.凝血酶对纯化的凝血因子VIII促凝蛋白的蛋白水解作用:激活与特定多肽生成的相关性。
Blood. 1983 Apr;61(4):807-11.

引用本文的文献

1
Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.人工染色体和类微型染色体附加体在基因治疗中的应用前景。
J Biomed Biotechnol. 2010;2010. doi: 10.1155/2010/642804. Epub 2010 Aug 24.
2
Gene therapy for haemophilia.血友病的基因治疗。
Br J Haematol. 2008 Mar;140(5):479-87. doi: 10.1111/j.1365-2141.2007.06942.x.
3
Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.人凝血因子VIII在人杂交细胞系HKB11中的表达。
Mol Biotechnol. 2006 Oct;34(2):165-78. doi: 10.1385/MB:34:2:165.
4
Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model.辅助依赖型腺病毒基因疗法可长期纠正犬血友病A模型中的凝血缺陷。
J Thromb Haemost. 2006 Jun;4(6):1218-1225. doi: 10.1111/j.1538-7836.2006.01901.x.
5
Correlation of rFVIII inactivation with aggregation in solution.重组人凝血因子VIII(rFVIII)失活与溶液中聚集的相关性。
Pharm Res. 2003 Apr;20(4):693-700. doi: 10.1023/a:1023271405005.
6
Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.通过椭圆偏振法测定凝血因子VIII及其轻链与磷脂酰丝氨酸/磷脂酰胆碱双层膜的结合。
Biochem J. 1995 Sep 1;310 ( Pt 2)(Pt 2):539-45. doi: 10.1042/bj3100539.
7
Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.一种抑制因子VIII促凝活性的鼠单克隆抗因子VIII抗体和一种人抗因子VIII同种抗体的结合区域在因子VIII重链的苏氨酸351-丝氨酸365氨基酸残基上的定位。
J Clin Invest. 1988 Jul;82(1):123-8. doi: 10.1172/JCI113559.
8
Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.
Ann Hematol. 1991 Sep;63(3):155-65. doi: 10.1007/BF01703248.
9
Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.新型重组因子VIII(缺乏大部分B结构域的因子VIII-δII)的结构与功能特性
Biochem J. 1991 Jul 1;277 ( Pt 1)(Pt 1):23-31. doi: 10.1042/bj2770023.
10
Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.关于血管性血友病因子上存在因子VIII的二级结合和保护位点的证据极不可能。
Biochem J. 1992 Feb 15;282 ( Pt 1)(Pt 1):129-37. doi: 10.1042/bj2820129.